$1000 investment in Intuitive Surgical, would have been worth $10,000 10 years ago

Trending News ☀️

Intuitive Surgical Intrinsic Value – INTUITIVE ($NASDAQ:ISRG): The company’s da Vinci surgical system enables surgeons to perform a variety of both common and complex procedures with minimally invasive techniques. The company’s strong financial performance is driven by continued adoption of the da Vinci surgical system by hospitals and surgeons worldwide.

Price History

The company’s products are used in a variety of surgeries, including gynecologic, urologic, general surgery, and head and neck surgery. The company’s products have been well-received by the medical community and have been featured in many positive news stories. On Friday, the company’s stock opened at $264.4 and closed at $262.1, up by 0.5% from the prior closing price of $260.8. The company’s products offer a number of advantages over traditional surgical methods, including increased precision, less blood loss, shorter recovery times, and less pain and scarring.

VI Analysis – Intuitive Surgical Intrinsic Value Calculator

Company’s fundamentals reflect its long term potential, below analysis on INTUITIVE SURGICAL are made simple by VI app. The fair value of INTUITIVE SURGICAL share is around $298.3, calculated by VI Line. Now INTUITIVE SURGICAL stock is traded at $262.1, a fair price undervalued by 12%.

VI Peers

The company’s da Vinci surgical system consists of a surgeon’s console, a patient-side cart and a vision system. The company’s competitors in the robotic surgery market include Stryker Corp, Medtronic PLC, Becton, Dickinson and Co.

– Stryker Corp ($NYSE:SYK)

With a market capitalization of $84.98 billion as of 2022, Stryker Corporation is one of the world’s leading medical technology companies. Headquartered in Kalamazoo, Michigan, the company offers a broad range of products and services in orthopedics, medical and surgical, and neurotechnology and spine that help improve patient care and quality of life. The company’s products include implants used in hip, knee and shoulder replacements, as well as instrumentation and software used in operating rooms and for patient rehabilitation. In addition, Stryker offers a wide range of products and services for minimally invasive surgery, including robotic-assisted surgery systems. The company’s return on equity was 10.79% as of 2022.

– Medtronic PLC ($NYSE:MDT)

Medtronic PLC is a medical technology company that develops and produces a variety of medical devices and software products. The company has a market capitalization of 112.31 billion as of 2022 and a return on equity of 7.49%. Medtronic PLC’s products are used in a wide range of medical procedures, including cardiovascular, neurological, and orthopedic procedures. The company’s products are sold in over 150 countries around the world.

– Becton, Dickinson and Co ($NYSE:BDX)

Becton, Dickinson and Co is a medical technology company that manufactures and sells medical devices, laboratory equipment, and diagnostic products. The company has a market cap of 64.37B as of 2022 and a return on equity of 6.42%. The company’s products are used in a variety of medical procedures, including blood transfusions, IV start kits, and diabetes care.

Summary

Investing in Intuitive Surgical, Inc. would have been a very wise decision 10 years ago. The company has seen incredible growth since then, and its share price has risen tenfold. The news coverage of the company has been mostly positive, and it is currently one of the most popular medical technology companies in the world. Intuitive Surgical, Inc. makes robotic surgical systems that are used in a variety of different medical procedures. The company’s products are extremely popular, and its technology is constantly evolving.

The company is also very well-funded, and it has a strong financial position. The company is innovative, and its products are in high demand. The company is also very well-positioned for future growth.